alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| 1.     | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                                      |
|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   |
| 2.     | The information contained in the Report fairly represents in all material respects, the financial condition and results of operations of Kraig Biocraft Laboratories, Inc. |

| Date:  May 28, 2010                                                  |
|---------------------------------------------------------------------------|
|                                                                      |
| Kraig Biocraft Laboratories, Inc.                                         |
|                                                                      |
| By: /s/ Kim Thompson              |
| Kim ThompsonChief Executive OfficerChief Financial and Accounting Officer |
#### UNITED STATES of America, Plaintiff-Appellee v. Raul ARAGUZ-RAMIREZ, Defendant-Appellant.

No. 11-40530

Summary Calendar.

United States Court of Appeals, Fifth Circuit.

April 2, 2012.

Renata Ann Gowie, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

Marjorie A. Meyers, Federal Public Defender, Margaret Christina Ling, Assistant Federal Public Defender, Federal Public Defender’s Office, Houston, TX, for Defendant-Appellant.

Before JONES, Chief Judge, and PRADO and ELROD, Circuit Judges.

PER CURIAM: *

Raul Araguz-Ramirez (Araguz) appeals from the judgment imposed after the district court revoked the term of supervised release that he was serving in connection with his 2004 illegal-reentry conviction. He concedes that he violated the conditions of his supervised release that prohibited him from committing another crime and from illegally reentering the United States. He argues, however, that the written judgment includes a clerical error insofar as it indicates that he additionally violated the conditions of his supervised *389release by committing the offense of public intoxication. The Government concedes the error.

Our review of the record confirms that whether Araguz had violated his supervised release conditions by committing the offense of public intoxication was not at issue during the revocation hearing. Because the district court made no mention a such a violation at any point in the revocation hearing, including during its oral pronouncement of sentence, the oral pronouncement of sentence conflicts with the written judgment, and the case is REMANDED FOR THE LIMITED PURPOSE of allowing the district court to conform its written judgment to its oral pronouncement of sentence. *See United States v. Martinez,*250 F.3d 941, 942 (5th Cir.2001).

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
Exhibit
32.1




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002*





I, John
Holcomb, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report
on Form 10-Q of Bonanza One, Inc. for the quarter ended March 31, 2010
fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934 and that information contained in such
Quarterly Report on Form 10-Q  fairly presents in all material
respects the financial condition and results of operations of Bonanza One,
Inc.





Date:
      May 11, 2010
              By:
              /s/John
      HolcombName:
              John
      HolcombTitle
              President.
      Principal Executive Officer
                and
      Principal Financial Officer





* The
foregoing certification is being furnished solely pursuant to 18 U.S.C. Section
1350 and is not being filed as part of the Report or as a separate disclosure
document.
```

[Federal Register: April 18, 2006 (Volume 71, Number 74)]
[Notices]
[Page 19878]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr18ap06-41]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

Time and Date: 11 a.m., Friday, May 5, 2006.

Place: 1155 21st St., NW., Washington, DC, 9th Floor Commission
Conference Room.

Status: Closed.

Matters To Be Considered: Surveillance Matters.

FOR FURTHER INFORMATION CONTACT: Jean A. Webb, 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 06-3727 Filed 4-14-06; 10:35 am]

BILLING CODE 6351-01-M
```
|        |        |                                                                                                                                                                          |
|--------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|   | (a)    | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and                                               |
|   |   |                                                                                                                                                                     |
|   | (b)    | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of MidWestOne Financial Group, Inc. |

|                                                      |                       |
|------------------------------------------------------|-----------------------|
| /s/ Gary J. Ortale                                   |
| Gary J. Ortale                                       |
| Executive Vice President and Chief Financial Officer |
| Date:                                                | November 3, 2010 |
```

[Federal Register: November 25, 2003 (Volume 68, Number 227)]
[Notices]
[Page 66082]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25no03-43]

=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY: Commodity Futures Trading Commission.

ACTION: Sunshine Act meetings.

-----------------------------------------------------------------------

Time and Date: 10:30 a.m., Wednesday, December 10, 2003.

Place: 1155 21st St., NW., Washington, DC, Room 1012.

Status: Closed.

Matters to be Considered: Rule Enforcement Review.

FOR FURTHER INFORMATION CONTACT: Jean A. Webb, (202) 418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 03-29618 Filed 11-21-03; 3:40 pm]
BILLING CODE 6351-01-M
```
**Exhibit 13.1**

 

**CERTIFICATION**

 

April 28, 2016

 

Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549

 

Ladies and Gentlemen:

 

The certification set forth below is being submitted to the Securities and Exchange Commission solely for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.

 

Elisabetta Ripa, the Chief Executive Officer and Adrián Calaza, the Chief Financial Officer of Telecom Argentina S.A. (“Telecom”) each certifies that, to the best of their knowledge:

 

1.             this Annual Report on Form 20-F (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.             the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Telecom.

 
|   | By:    | /s/ Elisabetta Ripa   |
|--------|--------|-----------------------|
|   |   | Name:                 | Elisabetta Ripa |
|   |   | Title:                | Chief Executive Officer |
|   |   |                  |   |
|   | By:    | s/ Adrián Calaza |
|   |   | Name:                 | Adrián Calaza |
|   |   | Title:                | Chief Financial Officer |

 

----
Exhibit 12.1
 Oncothyreon Inc. and Consolidated Subsidiaries
 Statement Regarding Computation of Ratio of Earnings to Fixed Charges
 For the NineMonths EndedSeptember 30,2009Earnings before fixed charges:Income/(loss) from continuing operations before income taxes,
minority interest and income/(loss) from equity investees
    
    $
    (9,464
    )Add fixed charges
    
    
    21Add amortization of capitalized interest
    
    
    Add distributed income of equity investees
    
    
    Subtract capitalized interest
    
    
    Income/(loss) before fixed charges
    
    $
    (9,443
    )Fixed charges:Interest expense
    
    $
    Amortization of debt expense
    
    
    Estimate of interest expense within rental expense
    
    
    21Preference security dividend requirements of consolidated subsidiaries
    
    
    Total fixed charges
    
    $
    21Deficiency of earnings available to cover fixed charges
    
    $
    (9,464
    )
Exhibit 32.1



          Certification Pursuant to 18 U.S.C. Section 1350, As Adopted
            Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002

I, Peter Wardle, the Chief Executive and Chief Financial Officer of Protosource
Corporation (the "Company"), certify, pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that to the best of my
knowledge:

(1)      the Annual Report on Form 10-KSB of the Company for the fiscal year
         ended December 31, 2004 (the "Report") fully complies with the
         requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act
         of 1934 (15 U.S.C. 78m or 78o(d)); and

(2)      the information contained in the Report fairly presents, in all
         material respects, the financial condition and results of operations of
         the Company.



Dated: March 30, 2007



                                                    /s/ PETER WARDLE
                                                    ----------------------------
                                                    Name: Peter Wardle
                                                    Title: Chief Executive and
                                                    Chief Financial Officer
Exhibit 10.41


INTELLISYNC CORPORATION


Summary
of Executive Officer Bonus Plan


                On
August 24, 2005, the Board of Directors (the “Board”) of Intellisync
Corporation (the “Company”) approved a change to the criteria for achievement
of executive officer bonuses.  Executive
officer bonuses for fiscal year 2006 will be paid based upon achievement of
gross revenue and operating profit metrics as determined by the compensation
committee of the Board.  The percentage
allocation will be determined annually by the compensation committee.  For fiscal year 2006, the potential bonus
allocations for the Company’s executive officers range from 83% to 20% of such
executive officer’s base compensation and are to be paid out based upon
achievement of gross revenue and operating profit metrics established by the
compensation committee.
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 115 Introduced in House (IH)]

111th CONGRESS
  1st Session
H. RES. 115

  Providing amounts for the expenses of the Committee on Science and 
            Technology in the One Hundred Eleventh Congress.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 4, 2009

 Mr. Gordon of Tennessee submitted the following resolution; which was 
           referred to the Committee on House Administration

_______________________________________________________________________

                               RESOLUTION

 
  Providing amounts for the expenses of the Committee on Science and 
            Technology in the One Hundred Eleventh Congress.

    Resolved,

SECTION 1. AMOUNTS FOR COMMITTEE EXPENSES.

    For the expenses of the Committee on Science and Technology 
(hereafter in this resolution referred to as the ``Committee''), 
including the expenses of all staff salaries, there shall be paid, out 
of the applicable accounts of the House of Representatives for 
committee salaries and expenses, not more than $15,190,423 for the One 
Hundred Eleventh Congress.

SEC. 2. SESSION LIMITATIONS.

    Of the amount specified in section 1--
            (1) not more than $7,233,535 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2009, and ending immediately before noon on January 
        3, 2010; and
            (2) not more than $7,956,888 shall be available for 
        expenses incurred during the period beginning at noon on 
        January 3, 2010, and ending immediately before noon on January 
        3, 2011.

SEC. 3. VOUCHERS.

    Payments under this resolution shall be made on vouchers authorized 
by the Committee, signed by the Chairman of the Committee, and approved 
in the manner directed by the Committee on House Administration.

SEC. 4. REGULATIONS.

    Amounts made available under this resolution shall be expended in 
accordance with regulations prescribed by the Committee on House 
Administration.
                                 <all>
```
```

[Federal Register: June 19, 2002 (Volume 67, Number 118)]
[Notices]
[Page 41698]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr19jn02-36]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act; Meeting

Agency Holding the Meeting: Commodity Futures Trading Commission.

Time and Date: 11:00 a.m., Friday, July 12, 2002.

Place: 1155 21st St., NW., Washington, DC, 9th Floor Conference Room.

Status: Closed.

Matters to Be Considered: Surveillance Matters.

Contact Person for More Information: Jean A. Webb. 202-418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 02-15537 Filed 6-17-02; 8:45 am]
BILLING CODE 6351-01-M
```

�
```

[Federal Register: April 20, 2005 (Volume 70, Number 75)]
[Notices]
[Page 20534]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20ap05-46]

=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

TIME AND DATE: 11 a.m., Friday, May 6, 2005.

PLACE: 1155 21st St., NW., Washington, DC, 9th Floor Commission
Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

FOR FURTHER INFORMATION CONTACT: Jean A. Webb, (202) 418-5100.

Jean A. Webb,
Secretary of the Commission.
[FR Doc. 05-8040 Filed 4-18-05; 2:19 pm]

BILLING CODE 6351-01-M
```
# C_2010352EN.01000501.xml

| 23.12.2010 | EN | Official Journal of the European Union | C 352/5 |
| --- | --- | --- | --- |

23.12.2010

EN

Official Journal of the European Union

C 352/5

---

Opinion of the Advisory Committee on restrictive practices and dominant position given at its meeting of 9 September 2010 regarding a draft decision relating to Case COMP/39.315 — ENI

Rapporteur: Hungary

2010/C 352/08

| 1. | The Advisory Committee shares the Commission's concerns expressed in its draft decision as communicated to the Advisory Committee on 9 September 2010 under Article 102 of the Treaty on the Functioning of the European Union (‘TFEU’) and Article 54 of the EEA Agreement. |
| --- | --- |

1.

The Advisory Committee shares the Commission's concerns expressed in its draft decision as communicated to the Advisory Committee on 9 September 2010 under Article 102 of the Treaty on the Functioning of the European Union (‘TFEU’) and Article 54 of the EEA Agreement.

| 2. | The Advisory Committee agrees with the Commission that the proceedings can be concluded by means of a decision pursuant to Article 9(1) of Regulation (EC) No 1/2003. |
| --- | --- |

2.

The Advisory Committee agrees with the Commission that the proceedings can be concluded by means of a decision pursuant to Article 9(1) of Regulation (EC) No 1/2003.

| 3. | The Advisory Committee agrees with the Commission that the commitments offered by ENI are suitable, necessary and proportionate. |
| --- | --- |

3.

The Advisory Committee agrees with the Commission that the commitments offered by ENI are suitable, necessary and proportionate.

| 4. | The Advisory Committee agrees with the Commission that, in light of the commitments offered by ENI, there are no longer grounds for action by the Commission, without prejudice to Article 9(2) of Regulation (EC) No 1/2003. |
| --- | --- |

4.

The Advisory Committee agrees with the Commission that, in light of the commitments offered by ENI, there are no longer grounds for action by the Commission, without prejudice to Article 9(2) of Regulation (EC) No 1/2003.

| 5. | The Advisory Committee asks the Commission to take into account any other points raised during the discussion. |
| --- | --- |

5.

The Advisory Committee asks the Commission to take into account any other points raised during the discussion.

| 6. | The Advisory Committee recommends the publication of its opinion in the Official Journal of the European Union. |
| --- | --- |

6.

The Advisory Committee recommends the publication of its opinion in the Official Journal of the European Union.

Official Journal of the European Union

---
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 260 | The Woodlands, Texas 77381

Chapter 1082

Natural Gas Fixed Swap - HSC - Platts Gas Daily

DESCRIPTION

A monthly cash settled swap based upon the average price published by Platts Gas Daily for the 

location specified in Floating Price A.

FLOATING PRICE A

The Floating Price for each contract month will be equal to the arithmetic average of the Platts 

Gas Daily HSC published price for each calendar day of the corresponding contract month.

CONTRACT UNIT AND VALUE

The contract unit shall be MMBtus (million British thermal units). Each contract shall be valued 

as the contract quantity in MMBtus multiplied by the settlement price.

LISTING CYCLE

Up to 120 consecutive monthly contract periods

PRICES AND FLUCTUATIONS

Prices shall be quoted in U.S. dollars and cents per MMBtu. The minimum price fluctuation shall 

be $0.001 per MMBtu. The minimum price increment will be $0.0001. There shall be no 

maximum price fluctuation.

TERMINATION OF TRADING

Posting of transactions shall cease on the last business day of the contract month.

FINAL SETTLEMENT

Delivery under the contract shall be by cash settlement. Final settlement, following termination 

of posting for a contract month, will be based on the Floating Price. The final settlement price 

will be the Floating Price calculated for each contract month.
```

[Federal Register: June 20, 1997 (Volume 62, Number 119)]
[Notices]
[Page 33605]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr20jn97-37]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 2:00 p.m., Monday, July 21, 1997.

PLACE: 1155 21st St. NW., Washington, DC, 9th Fl. Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Adjudicatory Matters.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 97-16416 Filed 6-18-97; 3:58 pm]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO    INDEX ========**

----
```

[Federal Register: January 20, 1998 (Volume 63, Number 12)]

[Notices]

[Page 2969]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr20ja98-37]



-----------------------------------------------------------------------



COMMODITY FUTURES TRADING COMMISSION





Sunshine Act Meeting



TIME AND DATE: 2:00 p.m., Wednesday, January 28, 1998.



PLACE: 1155 21st., N.W., Washington, D.C., 9th Floor Conference Room.



STATUS: Closed.



MATTERS TO BE CONSIDERED: Enforcement Matters.



CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.

Jean A. Webb,

Secretary of the Commission.

[FR Doc. 98-1412 Filed 1-15-98; 3:04 pm]

BILLING CODE 6351-01-M
```

----

**======== RETURN TO    INDEX ========**

----
```

[Federal Register: December 30, 1997 (Volume 62, Number 249)]
[Notices]
[Page 67847]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr30de97-68]

-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 2:00 p.m., Wednesday, January 28, 1998.

PLACE: 1155 21st St., N.W., Washington, D.C., 9th Floor Conference
Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Enforcement Objectives.

CONTACT PERSON FOR MORE INFORMATION: Jean A. Webb, 202-418-5100.
Jean A. Webb,
Secretary of the Commission.
[FR Doc. 97-34062 Filed 12-24-97; 11:12 am]
BILLING CODE 6351-01-M
```

----

**======== RETURN TO    INDEX ========**

----
[Federal Register Volume 66, Number 12 (Thursday, January 18, 2001)]
[Notices]
[Page 4843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-1452]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Arthritis and Musculoskeletal and Skin 
Diseases; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personnel information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Arthritis and Musculoskeletal and Skin 
Diseases Special Grants Review Committee.
    Date: February 20, 2001.
    Time: 8:30 AM to 3:30 PM.
    Agenda: To review and evaluate grant applications.
    Place: Double Tree Hotel, 1750 Rockville Pike, Rockville, MD 
20852.
    Contact Person: John R. Lymangrover, PhD, Scientific Review 
Administrator, National Institutes of Health, NIAMS, Natcher Bldg., 
Room 5As25N, Bethesda, MD 20892, 301-594-4952.

(Catalogue of Federal Domestic Assistance Program Nos. 93.846, 
Arthritis, Musculoskeletal and Skin Diseases Research, National 
Institutes of Health, HHS)

    Dated: January 9, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-1452 Filed 1-12-01; 8:45 am]
BILLING CODE 4140-01-M